Press Release: Royer Biomedical, Inc. receives FDA approval to proceed with Human Testing (IND 111446) on 5/25/2012 for its AppliGel Polymer Drug Delivery System Quote: Royer Biomedical, Inc. (RBI) received FDA approval to proceed with Human Testing of AppliGel-G (Gentamicin) in management of Diabetic Foot Ulcers (DFU).
Continued here:
AppliGel-G approved for testing in diabetic foot ulcers
